πŸ‡ΊπŸ‡Έ FDA
Patent

US 10736864

Immunotherapeutic agent

granted A61KA61K31/201A61K31/231

Quick answer

US patent 10736864 (Immunotherapeutic agent) held by The Regents of the University of Colorado, a Body Corporate expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/201, A61K31/231, A61K9/0019, A61P